Rebecca Nebel, PhD

is a Senior Director of Science and Regulatory Advocacy at PhRMA and leads advocacy efforts to advance FDA regulatory policy on key issues including digital health, regulatory information and technology, and combination products. Prior to joining PhRMA, Rebecca was the Director of Scientific Programs at the Society for Women’s Health Research and a project manager at the National Institutes of Health. She was also a Christine Mirzayan Science & Technology Policy Graduate Fellow at the National Academies of Sciences, Engineering, and Medicine. Rebecca received her PhD in biomedical sciences from Albert Einstein College of Medicine and her BS in biological sciences from Binghamton University.